Richard C. Breeden - 02 Jun 2026 Form 4 Insider Report for STERIS plc (STE)

Reporting relationship: Director
Issuer ticker: STE
Reported as of: 02 Jun 2026
Net transaction value: -$310,284
SEC form: 4
Accepted by SEC: 04 Jun 2026, 16:31:09 UTC
Prior SEC filing: 15 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney

Key filing fact

Richard C. Breeden filed Form 4 for STERIS plc (STE) on 04 Jun 2026.

Key facts

This page summarizes Richard C. Breeden's Form 4 filing for STERIS plc (STE).
3 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 04 Jun 2026, 16:31.

Change

Previous filing in this sequence was filed on 15 Aug 2025.
Current net transaction value: -$310,284.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001300622 Primary reporting owner

Breeden Richard C

Relationship: Director
Address: C/O 70 SIR JOHN ROGERSON'S QUAY, DUBLIN 2, IRELAND
Signature: /s/ John P. Ubbing, Authorized Representative under Power of Attorney
Signature date: 04 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STE transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +3,781
Change %: +10%
Price: $71.40^*
Shares after: 40,445
Date: 02 Jun 2026
Ownership: Direct

STE transaction

Ordinary Shares

Sale

Transaction value: $310,284
Shares: -1,481
Change %: -3.7%
Price: $209.51
Shares after: 38,964
Date: 02 Jun 2026
Ownership: Direct
Footnotes: F1

STE holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 27,242
Date: 02 Jun 2026
Ownership: See Footnotes Below
Footnotes: F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STE transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -3,781
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 02 Jun 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 3,781
Exercise price: $71.40
Footnotes: F4

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

Price reflects a weighted average sale price for multiple transactions ranging from $209.50 to $209.53 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Footnote F2

Richard C. Breeden is the managing member of Breeden Capital Partners LLC, and managing member and chairman and chief executive officer of Breeden Capital Management LLC. Breeden Capital Partners LLC (the "General Partner") is in turn the general partner of Breeden Partners L.P. (the "Fund").

Footnote F3

Pursuant to Rule 16a-1(a)(2)(ii)(B) of the Securities Exchange Act of 1934, as amended, Mr. Breeden in his capacity as managing member, as well as chairman and chief executive officer of Breeden Capital Management LLC and as the managing member of Breeden Capital Partners LLC, may be deemed to be the indirect beneficial owner of the ordinary shares owned by the Fund and its General Partner, and may be deemed to have beneficial ownership of all such shares. Mr. Breeden disclaims beneficial ownership over 1,358 of these shares held by Breeden Partnership LLP.

Footnote F4

This option to purchase 3,781 STERIS plc ordinary shares, which is fully vested, was received in connection with the redomiciliation of STERIS plc to Ireland in March 2019 in exchange for an option to purchase 3,781 ordinary shares for $71.40 per share in STERIS plc prior to the redomiciliation ("Old STERIS"), subject to the same terms and conditions as the original Old STERIS stock option.